Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2150 of 3284 entries
View as:

Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History

Phase: N/A Priority: Normal
NCT ID: NCT02138916 Org: User:
Start: 06/13/14 End: 04/10/18 Due: 04/10/19

Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT05374603 Org: User:
Start: 11/23/22 End: 08/30/25 Due: 08/30/26

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

Phase: N/A Priority: Normal
NCT ID: NCT00065572 Org: User:
Start: 08/31/03 End: 02/29/04 Due: 02/28/05

Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.

Phase: N/A Priority: Normal
NCT ID: NCT01559090 Org: User:
Start: 04/20/12 End: 02/21/17 Due: 02/21/18

Nexium RESPONSE Trial

Phase: N/A Priority: Normal
NCT ID: NCT00318968 Org: User:
Start: 05/31/06 End: 11/30/07 Due: 11/30/08

Electronic Study for Anastrozole Pharmacovigilance Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00558168 Org: User:
Start: 01/31/04 End: 07/31/08 Due: 07/31/09

A Phase I, Open-Label, 2 Part Multicentre Study to Assess the Safety and Efficacy of Olaparib in Combination With Carboplatin in Patients With Advanced HER-2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02561832 Org: User:
Start: 11/06/15 End: 02/01/17 Due: 02/01/18

Symptoms and Management Strategies in Gastroesophageal Reflux Disease (GERD)

Phase: N/A Priority: Normal
NCT ID: NCT00768443 Org: User:
Start: 09/30/08 End: 02/28/09 Due: 02/28/10

Evaluation of the Effect of the Association of Proton Pump Inhibitor (PPIs) With Non-Steriodal Anti-Inflamatories (NSAIDs) in Work Leave Time.

Phase: N/A Priority: Normal
NCT ID: NCT00717119 Org: User:
Start: 04/30/08 End: 08/31/08 Due: 08/31/09

A Safety Study of AZD4041 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05233085 Org: User:
Start: 12/17/21 End: 06/07/22 Due: 06/07/23

Ph1 to Assess Safety, Tolerability of Tremelimumab/ Tremelimumab+MEDI4736 in Japanese Solid Malignancies/ Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT02141347 Org: User:
Start: 05/22/14 End: 01/27/17 Due: 01/27/18

A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)

Phase: N/A Priority: Normal
NCT ID: NCT06575517 Org: User:
Start: 10/15/24 End: 09/30/25 Due: 09/30/26

Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck

Phase: N/A Priority: Normal
NCT ID: NCT02499328 Org: User:
Start: 08/06/15 End: 08/12/25 Due: 08/12/26

Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00868231 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Phase: N/A Priority: Normal
NCT ID: NCT00926393 Org: User:
Start: 06/30/09 End: 08/31/09 Due: 08/31/10

A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT06173570 Org: User:
Start: 01/19/24 End: 09/30/24 Due: 09/30/25

Atypical Antipsychotics in Improvement of Quality of Life in Bipolar Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00745966 Org: User:
Start: 07/31/08 End: - Due: -

Epidemiology of Thrombotic Thrombocytopenia Syndrome in Integrated Health-care Database in England

Phase: N/A Priority: Normal
NCT ID: NCT05222750 Org: User:
Start: 03/01/22 End: 05/25/23 Due: 05/25/24

Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases

Phase: N/A Priority: Normal
NCT ID: NCT06077045 Org: User:
Start: 01/18/23 End: 07/04/23 Due: 07/04/24

Assessment of Treatment Patterns of Severe Asthmatic Patients Across the Gulf Region - SevEos Study

Phase: N/A Priority: Normal
NCT ID: NCT03387722 Org: User:
Start: 12/31/17 End: 01/03/19 Due: 01/03/20

Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

Phase: N/A Priority: Normal
NCT ID: NCT00622323 Org: User:
Start: 02/29/08 End: 09/30/09 Due: 09/30/10

Nis Register Study Comparing Seroquel and Seroquel Prolong

Phase: N/A Priority: Normal
NCT ID: NCT00965536 Org: User:
Start: 08/31/09 End: 12/31/10 Due: 12/31/11

A Study to Assess the Pharmacokinetics of AZD4831 When Administered Alone and in Combination With Itraconazole

Phase: N/A Priority: Normal
NCT ID: NCT05236543 Org: User:
Start: 02/18/22 End: 08/12/22 Due: 08/12/23

A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02087423 Org: User:
Start: 02/25/14 End: 03/26/25 Due: 03/26/26

An Open-label Study in Healthy Participants to Evaluate AZD0780 as an Object or Precipitant of CYP3A4-mediated Drug-drug Interactions

Phase: N/A Priority: Normal
NCT ID: NCT06671405 Org: User:
Start: 09/25/24 End: 02/17/25 Due: 02/17/26